Pemetrexed RTD regulatory update

Eagle said it submitted an NDA to FDA for pemetrexed RTD to treat locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) and mesothelioma in combination with cisplatin. The pro...